Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved amyloid burden quantification with nonspecific estimates using deep learning.
Liu H, Nai YH, Saridin F, Tanaka T, O' Doherty J, Hilal S, Gyanwali B, Chen CP, Robins EG, Reilhac A. Liu H, et al. Among authors: reilhac a. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1842-1853. doi: 10.1007/s00259-020-05131-z. Epub 2021 Jan 7. Eur J Nucl Med Mol Imaging. 2021. PMID: 33415430 Free PMC article.
Head-to-head comparison of amplified plasmonic exosome Aβ42 platform and single-molecule array immunoassay in a memory clinic cohort.
Tanaka T, Ruifen JC, Nai YH, Tan CH, Lim CZJ, Zhang Y, Stephenson MC, Hilal S, Saridin FN, Gyanwali B, Villaraza S, Robins EG, Ihara M, Schöll M, Zetterberg H, Blennow K, Ashton NJ, Shao H, Reilhac A, Chen C. Tanaka T, et al. Among authors: reilhac a. Eur J Neurol. 2021 May;28(5):1479-1489. doi: 10.1111/ene.14704. Epub 2021 Jan 23. Eur J Neurol. 2021. PMID: 33370497
Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.
Chong JR, Ashton NJ, Karikari TK, Tanaka T, Saridin FN, Reilhac A, Robins EG, Nai YH, Vrooman H, Hilal S, Zetterberg H, Blennow K, Lai MKP, Chen CP. Chong JR, et al. Among authors: reilhac a. Alzheimers Dement. 2021 Oct;17(10):1649-1662. doi: 10.1002/alz.12332. Epub 2021 Mar 31. Alzheimers Dement. 2021. PMID: 33792168
11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial.
Puar TH, Khoo CM, Tan CJ, Tong AKT, Tan MCS, Teo AE, Ng KS, Wong KM, Reilhac A, O'Doherty J, Gomez-Sanchez CE, Kek PC, Yee S, Tan AWK, Chuah MB, Lee DHM, Wang KW, Zheng CQ, Shi L, Robins EG, Foo RSY; for the PA CURE investigators. Puar TH, et al. Among authors: reilhac a. J Hypertens. 2022 Jun 1;40(6):1179-1188. doi: 10.1097/HJH.0000000000003132. J Hypertens. 2022. PMID: 35703880 Clinical Trial.
Improved quantification of amyloid burden and associated biomarker cut-off points: results from the first amyloid Singaporean cohort with overlapping cerebrovascular disease.
Tanaka T, Stephenson MC, Nai YH, Khor D, Saridin FN, Hilal S, Villaraza S, Gyanwali B, Ihara M, Vrooman H, Weekes AA, Totman JJ, Robins EG, Chen CP, Reilhac A. Tanaka T, et al. Among authors: reilhac a. Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):319-331. doi: 10.1007/s00259-019-04642-8. Epub 2019 Dec 20. Eur J Nucl Med Mol Imaging. 2020. PMID: 31863136
72 results